D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Qualcomm
QCOM
|
+$555M |
| 2 |
Marathon Petroleum
MPC
|
+$538M |
| 3 |
Ford
F
|
+$529M |
| 4 |
Walmart
WMT
|
+$508M |
| 5 |
Apple
AAPL
|
+$499M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$716M |
| 2 |
Merck
MRK
|
+$498M |
| 3 |
Meta Platforms (Facebook)
META
|
+$425M |
| 4 |
McDonald's
MCD
|
+$369M |
| 5 |
Wells Fargo
WFC
|
+$362M |
Sector Composition
| 1 | Technology | 20.88% |
| 2 | Consumer Discretionary | 13.12% |
| 3 | Healthcare | 9.93% |
| 4 | Communication Services | 9.58% |
| 5 | Financials | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Spyre Therapeutics
SYRE
$978M
| $320K | ﹤0.01% |
1,839
-671
| -27% | -$117K |
|
2902
Diodes
DIOD
$2.52B
| $319K | ﹤0.01% |
4,001
-5,562
| -58% | -$443K |
|
2903
Elbit Systems
ESLT
$23.4B
| $319K | ﹤0.01% |
+2,462
| New | +$319K |
|
|
EMKR
2904
DELISTED
Emcore Corp
EMKR
| $319K | ﹤0.01% |
+3,465
| New | +$319K |
|
2905
Essential Properties Realty Trust
EPRT
$5.94B
| $317K | ﹤0.01% |
+11,727
| New | +$317K |
|
2906
Franklin Electric
FELE
$4.31B
| $317K | ﹤0.01% |
3,927
-1,650
| -30% | -$133K |
|
2907
Kforce
KFRC
$583M
| $315K | ﹤0.01% |
5,006
-1,273
| -20% | -$80.1K |
|
|
COHR
2908
DELISTED
Coherent Inc
COHR
| $315K | ﹤0.01% |
1,193
-62,299
| -98% | -$16.4M |
|
|
NXU.U
2909
DELISTED
Novus Capital Corporation II Units, each consisting of one share of Class A common stock and one thi
NXU.U
| $315K | ﹤0.01% |
31,082
+20,656
| +198% | +$209K |
|
|
RESN
2910
DELISTED
Resonant Inc.
RESN
| $314K | ﹤0.01% |
+97,735
| New | +$314K |
|
2911
Charles River Laboratories
CRL
$7.86B
| $311K | ﹤0.01% |
+842
| New | +$311K |
|
2912
Sensient Technologies
SXT
$4.57B
| $311K | ﹤0.01% |
3,595
-50,060
| -93% | -$4.33M |
|
|
SFE
2913
DELISTED
Safeguard Scientifics, Inc.
SFE
| $311K | ﹤0.01% |
40,109
+17,222
| +75% | +$134K |
|
2914
James Hardie Industries plc
JHX
$11.6B
| $310K | ﹤0.01% |
9,118
-2,390
| -21% | -$81.3K |
|
2915
CarMax
KMX
$9.19B
| $310K | ﹤0.01% |
2,400
-156,515
| -98% | -$20.2M |
|
2916
Ferrari
RACE
$85.4B
| $309K | ﹤0.01% |
1,500
-49
| -3% | -$10.1K |
|
2917
South Plains Financial
SPFI
$651M
| $309K | ﹤0.01% |
13,357
-166
| -1% | -$3.84K |
|
|
ARI
2918
Apollo Commercial Real Estate
ARI
$1.53B
| $308K | ﹤0.01% |
19,288
-414,134
| -96% | -$6.61M |
|
2919
First Industrial Realty Trust
FR
$6.97B
| $307K | ﹤0.01% |
5,883
-401,520
| -99% | -$21M |
|
2920
Heritage Financial
HFWA
$845M
| $306K | ﹤0.01% |
+12,246
| New | +$306K |
|
2921
Mitek Systems
MITK
$477M
| $306K | ﹤0.01% |
15,877
-249
| -2% | -$4.8K |
|
2922
MSCI
MSCI
$45.3B
| $306K | ﹤0.01% |
574
-2,830
| -83% | -$1.51M |
|
2923
Supernus Pharmaceuticals
SUPN
$2.62B
| $306K | ﹤0.01% |
9,923
-4,841
| -33% | -$149K |
|
2924
Zymeworks
ZYME
$1.24B
| $305K | ﹤0.01% |
8,784
-10,558
| -55% | -$367K |
|
2925
Orchestra BioMed
OBIO
$141M
| $304K | ﹤0.01% |
+29,801
| New | +$304K |
|